History of Present Illness: 73 year old male with Klatskin tumor s/p [**Year (4 digits) **] stenting of L hepatic duct and IR placement of internal/external R PTBD who presented for an elective resection of the cholangiocarcinoma.
Past Medical History: Past Medical History: Klatskin tumor, GERD, Barrett's esophagus  Past Surgical History: Placement of percutaneous R internal and external biliary drain [**2104-12-9**], [**Year (4 digits) **] stenting of L hepatic duct [**2104-11-27**], Segmental right colectomy for polyp [**2100**], Open cholecystectomy [**2098**]  Current Medications: Omeprazole 20 mg daily, Aspirin 81 mg daily, Flomax 0.4mg daily, multivitamin, reglan 10qachs  Social History: Denies tobacco use past/present, EtOH and recreational drug use.
Family History: Mother - Breast Ca; Sister - melanoma   Physical Exam: VS: 99.9  96.9  68  92/62  20  98RA gen: comfortable, NAD CV: RRR pulm: CTA b/l abdomen: thin, soft, ND/NT, + BS, staples removed, steri-strips in place, incision c/d/i, no edema/ no erythema extremities: no edema  Pertinent Results: [**2105-1-13**] 11:40AM BLOOD WBC-6.3# RBC-3.40* Hgb-11.2* Hct-32.4* MCV-95 MCH-33.0* MCHC-34.7 RDW-15.8* Plt Ct-248 [**2105-1-14**] 08:40AM BLOOD WBC-8.9 RBC-3.25* Hgb-10.9* Hct-31.2* MCV-96 MCH-33.4* MCHC-34.8 RDW-15.7* Plt Ct-223 [**2105-1-15**] 09:10AM BLOOD WBC-17.4*# RBC-3.56* Hgb-11.5* Hct-33.8* MCV-95 MCH-32.2* MCHC-33.9 RDW-15.3 Plt Ct-225 [**2105-1-16**] 05:45AM BLOOD WBC-10.8 RBC-2.97* Hgb-9.6* Hct-28.3* MCV-95 MCH-32.3* MCHC-33.9 RDW-15.1 Plt Ct-196 [**2105-1-16**] 09:45AM BLOOD WBC-10.3 RBC-3.18* Hgb-10.2* Hct-30.1* MCV-95 MCH-32.2* MCHC-33.9 RDW-15.2 Plt Ct-230 [**2105-1-17**] 06:25AM BLOOD WBC-9.5 RBC-3.01* Hgb-9.8* Hct-27.9* MCV-93 MCH-32.5* MCHC-35.0 RDW-15.0 Plt Ct-227 [**2105-1-18**] 05:45AM BLOOD WBC-6.1 RBC-2.90* Hgb-9.3* Hct-27.2* MCV-94 MCH-32.1* MCHC-34.2 RDW-15.0 Plt Ct-266 [**2105-1-22**] 04:20AM BLOOD WBC-5.7 RBC-2.99* Hgb-9.9* Hct-28.9* MCV-96 MCH-33.0* MCHC-34.2 RDW-15.0 Plt Ct-407# [**2105-1-23**] 03:43AM BLOOD WBC-17.8*# RBC-2.98* Hgb-9.7* Hct-28.3* MCV-95 MCH-32.5* MCHC-34.2 RDW-14.8 Plt Ct-347 [**2105-1-24**] 05:15AM BLOOD WBC-6.3# RBC-3.01* Hgb-9.8* Hct-29.2* MCV-97 MCH-32.5* MCHC-33.5 RDW-14.9 Plt Ct-332 [**2105-1-13**] 11:40AM BLOOD Glucose-108* UreaN-13 Creat-0.7 Na-139 K-4.2 Cl-104 HCO3-26 AnGap-13 [**2105-1-14**] 08:40AM BLOOD Glucose-105* UreaN-13 Creat-0.7 Na-135 K-4.3 Cl-101 HCO3-28 AnGap-10 [**2105-1-15**] 09:10AM BLOOD Glucose-113* UreaN-13 Creat-0.7 Na-134 K-4.6 Cl-101 HCO3-28 AnGap-10 [**2105-1-16**] 05:45AM BLOOD Glucose-466* UreaN-16 Creat-0.7 Na-127* K-5.9* Cl-102 HCO3-24 AnGap-7* [**2105-1-16**] 09:45AM BLOOD Glucose-137* UreaN-17 Creat-0.7 Na-134 K-4.4 Cl-101 HCO3-27 AnGap-10 [**2105-1-17**] 06:25AM BLOOD Glucose-118* UreaN-20 Creat-0.8 Na-132* K-4.0 Cl-101 HCO3-25 AnGap-10 [**2105-1-18**] 05:45AM BLOOD Glucose-111* UreaN-15 Creat-0.7 Na-137 K-3.9 Cl-105 HCO3-26 AnGap-10 [**2105-1-21**] 10:50AM BLOOD Glucose-128* UreaN-13 Creat-0.7 Na-137 K-4.0 Cl-103 HCO3-29 AnGap-9 [**2105-1-22**] 04:00PM BLOOD Glucose-94 UreaN-11 Creat-0.8 Na-139 K-4.0 Cl-103 HCO3-25 AnGap-15 [**2105-1-23**] 03:43AM BLOOD Glucose-118* UreaN-11 Creat-0.6 Na-138 K-4.1 Cl-105 HCO3-27 AnGap-10 [**2105-1-24**] 05:15AM BLOOD Glucose-117* UreaN-9 Creat-0.8 Na-139 K-4.1 Cl-106 HCO3-27 AnGap-10 [**2105-1-13**] 11:40AM BLOOD ALT-98* AST-140* AlkPhos-303* TotBili-2.5* [**2105-1-14**] 08:40AM BLOOD ALT-143* AST-168* AlkPhos-283* TotBili-2.5* [**2105-1-15**] 09:10AM BLOOD ALT-122* AST-113* AlkPhos-268* TotBili-2.5* [**2105-1-16**] 05:45AM BLOOD ALT-72* AST-58* AlkPhos-194* TotBili-1.8* [**2105-1-17**] 06:25AM BLOOD ALT-61* AST-47* AlkPhos-206* TotBili-2.0* [**2105-1-18**] 05:45AM BLOOD ALT-51* AST-37 AlkPhos-221* TotBili-1.8* [**2105-1-19**] 06:55AM BLOOD ALT-48* AST-43* AlkPhos-297* TotBili-1.9* DirBili-1.3* IndBili-0.6 [**2105-1-20**] 09:00AM BLOOD ALT-67* AST-75* AlkPhos-499* TotBili-2.5* [**2105-1-21**] 10:50AM BLOOD ALT-59* AST-58* AlkPhos-499* TotBili-2.1* [**2105-1-22**] 04:20AM BLOOD ALT-59* AST-67* AlkPhos-551* TotBili-2.1* [**2105-1-22**] 04:00PM BLOOD ALT-65* AST-87* AlkPhos-602* Amylase-91 TotBili-2.6* [**2105-1-23**] 03:43AM BLOOD ALT-57* AST-63* AlkPhos-502* TotBili-1.9* [**2105-1-24**] 05:15AM BLOOD ALT-41* AST-36 AlkPhos-434* TotBili-1.6* [**2105-1-13**] 11:40AM BLOOD Albumin-3.1* Calcium-8.2* Phos-3.4 Mg-1.8 [**2105-1-14**] 08:40AM BLOOD Albumin-3.0* Calcium-7.7* Phos-3.0 Mg-1.8 [**2105-1-15**] 09:10AM BLOOD Calcium-7.9* Phos-2.0* Mg-2.3 [**2105-1-16**] 05:45AM BLOOD Albumin-2.1* Calcium-6.8* Phos-1.2* Mg-2.0 [**2105-1-16**] 09:45AM BLOOD Calcium-7.6* Phos-1.1* Mg-2.1 [**2105-1-17**] 06:25AM BLOOD Albumin-2.5* Calcium-7.7* Phos-3.0# Mg-2.1 [**2105-1-18**] 05:45AM BLOOD Albumin-2.3* Calcium-7.7* Phos-2.4* Mg-2.1 [**2105-1-21**] 10:50AM BLOOD Albumin-2.7* Calcium-8.0* Phos-2.9 Mg-2.0 [**2105-1-22**] 04:00PM BLOOD Albumin-2.4* Calcium-7.8* Phos-2.3* Mg-1.6 [**2105-1-23**] 03:43AM BLOOD Albumin-2.2* Calcium-7.5* Phos-2.7 Mg-2.2 [**2105-1-24**] 05:15AM BLOOD Albumin-2.4* Calcium-7.7* Phos-2.3* Mg-2.1  imaging: [**2105-1-13**] CXR In comparison with study of [**1-6**], there has been placement of a right IJ sheath that extends to about the junction of the jugular and subclavian veins.
[**2105-1-16**] video swallow Penetration of thin liquids with residue in the valleculae.
[**2105-1-20**] video swallow 1.
Penetration with thin liquid without aspiration.
[**2105-1-22**] [**Year (4 digits) **] The previously placed Cotton-[**Doctor Last Name **] plastic biliary stent and the percutaneous internalized biliary drain placed by IR were found at the major papilla.
An 8mm x 100mm [**Company 2267**] WallFlex Uncovered metal biliary stent was placed successfully in the right hepatic duct with the distal edge just entering the dudenum REF: 7063 LOT: [**Numeric Identifier 88122**].
Next, an 8mm x 80mm [**Company 2267**] WallFlex Uncovered metal biliary stent was placed successfully in the left hepatic duct with the distal edge in the distal CBD REF: 7062 LOT: [**Numeric Identifier 88123**].
A second 8mm x 60mm [**Company 2267**] WallFlex Uncovered metal biliary stent was placed successfully within the left duct WallFlex stent extending from the proximal CBD and exiting at the major papilla REF: 7061 LOT: [**Numeric Identifier 88124**].
[**2105-1-14**] Blood culture - no growth final [**2105-1-15**] Urine culture - no growth final [**2105-1-15**] Blood culture - no growth final [**2105-1-22**] Urine culture - no growth final [**2105-1-22**] Blood culture - pending [**2105-1-22**] Fungal culture - pending   Brief Hospital Course: The patient was admitted to the Hepatobiliary Surgical Service for an elective resection of the cholangiocarcinoma.
The influenza A and B were tested as well as urine and blood cultures.
After the recovery in the PACU, the patient arrived on the floor NPO, on IV fluids, with a foley catheter, and PCA dilaudid for pain control.
When tolerating oral intake, the patient was transitioned to oral pain medications.
Patient reported one episode of chest pain, for which EKG was obtained as well as a set of cardiac markers.
Pulmonary: Patient was diagnosed with Influenza A and was given osteamvir for a total of 5 days.
He was placed on respiratory isolation for the entire treatment period.
He remained stable from a pulmonary standpoint; vital signs were routinely monitored.
GI/GU/FEN: Post-operatively, the patient was made NPO with IV fluids.
Patient had a speech and swallow evaluation which was initially concerning for potential aspiration, thus he was continued NPO for a few more day.
Patient had the CBD stent removed by [**Year (4 digits) **] and at the same time his PTC catheter was removed by IR and internal metal stent was placed.
Following the procedure patient became transiently bacteremic and septic.
He received fluid resuscitation and required short administration of vasopressors.
He also received broad spectrum antibiotics.
As mentioned he received treatment for influenza A and for bacteremia post-procedure.
He was discharged on 3 additional doses of ciprofloxacin to complete the course.
Hematology: The patient's complete blood count was examined routinely; no blood product transfusions were required.
Prophylaxis: The patient received subcutaneous heparin and venodyne boots were used during this stay; he ambulates early.
The patient was tolerating a regular soft diet with boosts, ambulating, voiding without assistance, and pain was well controlled on non-narcotic pain medications.
- metoclopramide 10 mg Tablet Sig: One (1) Tablet PO TID W/MEALS (3 TIMES A DAY WITH MEALS).
- tamsulosin 0.4 mg Capsule, Ext Release 24 hr Sig: One (1) Capsule, Ext Release 24 hr PO HS (at bedtime).
2. omeprazole 20 mg Capsule, Delayed Release(E.C.)
3. metoclopramide 10 mg Tablet Sig: One (1) Tablet PO TID W/MEALS (3 TIMES A DAY WITH MEALS).
4. tamsulosin 0.4 mg Capsule, Ext Release 24 hr Sig: One (1) Capsule, Ext Release 24 hr PO HS (at bedtime).
5. ciprofloxacin 500 mg Tablet Sig: One (1) Tablet PO twice a day for 3 days.
Please resume all regular home medications , unless specifically advised not to take a particular medication.
Also, please take any new medications as prescribed.
Avoid driving or operating heavy machinery while taking pain medications.
*You may shower, and wash surgical incisions with a mild soap and warm water.
Medications: - take Ciprofloxacin as prescribed.
- please take all your home medications as you did prior to hospitalization  Followup Instructions: Please follow up with your PCP [**Last Name (NamePattern4) **] [**12-7**] weeks.
